HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population

British Journal of Dermatology

Volumn 139, Issue 6, 1998, Pages 978-983

  Jee, Shiou Hwa ^a   Tsai, Tsen Fang ^a   Tsai, Wei Ling ^a   Liaw, Shwu Huey ^a   Chang, Chun Hsiang ^a   Hu, Chung Yi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS VULGARIS; T LYMPHOCYTE ACTIVATION; CHILD; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MIDDLE AGED; PSORIASIS; TAIWAN;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSORIASIS; TAIWAN;

EID: 0032216750     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02552.x     Document Type: Article

References (25)

1. Christophers E, Sterry W. Psoriasis. In: Dermatology in General Medicine (Fitzpatrick TB, Eisen AZ, Wolff K et al. eds), 4th edn. New York: McGraw-Hill Book Company, 1993: 489-514.
2. Aoki T. Psoriasis in Japan. Arch Dermatol 1971; 104: 328-9.
3. Lin XR. Psoriasis in China. J Dermatol 1993; 20: 746-55.
4. Russell TJ, Shultes LM, Kuban DJ. Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 1972; 287: 738-40.
5. White S, Newcomer VD, Mickey MR, Terasaki PI. Distribution of HLA antigen frequency in psoriasis. N Engl J Med 1972; 287: 740-3.
6. Marcusson JA, Johannesson A, Mäller E. HLA A, B, C and DR antigens in psoriasis. Tissue Antigens 1981; 17: 525-9.
7. Tiilikainen A, Lassus A, Karvonen J et al. Psoriasis and HLA-Cw6. Br J Dermatol 1980; 102: 179-84.
8. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis. J Am Acad Dermatol 1990; 13: 450-6.
9. Ozawa A, Ohkido M, Tsuji K. Some recent advances in HLA and skin diseases. J Am Acad Dermatol 1981; 4: 205-30.
10. Scharf SJ, Griffith RL, Erlich HA. Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol 1991; 30: 190-201.
11. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-35.
12. Bugawan TL, Saiki RK, Levenson CH et al. The use of non-radioactive oligonucleotide probes to analyze enzymatically amplified DNA for prenatal diagnosis and forensic HLA typing. Bio/Technology 1988; 6: 943-7.
13. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991; 33: 163-70.
14. Bugawan TL, Begovich AB, Erlich HA. Rapid HLA-DPβ typing using enzymatically amplified DNA and non-radioactive sequence-specific oligonucleotide probes. Immunogenetics 1990; 32: 231-41.
15. WHO Nomenclature Committee. Nomenclature for factors of the HLA system. 1995. Tissue Antigens 1995; 46: 1-18.
16. Santamaria P, Boyce-Jacino MT, Lindstrom AL et al. Detection of novel sequence heterogeneity and haplotype diversity of HLA class II genes. Immunogenetics 1991; 33: 374-87.
17. Hu CY, Allen M, Chuang LM et al. Association of IDDM in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol 1993; 38: 105-14.
18. Schmitt-Egenolf M, Boehncke W-H, Ständer M et al. Oligonucleotide typing reveals association of type I psoriasis with HLA-DRB1*0701/2, -DQA1*0201, DQB1*0303 extended haplotype. J Invest Dermatol 1993; 100: 749-52.
19. Schmitt-Egenolf M, Eiermann TH, Boehncke W-H et al. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population-and family based study. J Invest Dermatol 1996; 106: 711-14.
20. Ikäheimo I, Silvennoinen-Kassinen S, Karvonen J et al. Immunogenetic profile of PSV: association with haplotypes A2, B13, Cw6, DR7, DQA1*0201 and A1, B17, Cw6, DR7, DQA1*0201. Arch Dermatol Res 1996; 288: 63-7.
21. Fakler JW, Schmitt-Egenolf M, Vejbaesya S et al. Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum Immunol 1994; 40: 299-302.
22. Gregerson PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
23. Hammer J, Gallazzi F, Bono E et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med 1995; 181: 1847-55.
24. Stern LJ, Brown JH, Jardetzky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994; 368: 215-21.
25. Sinigaglia F, Hammer J. Prediction of major histocompatibility complex-binding sequences with protein antigens. Biochem Soc Trans 1995; 23: 675-7.